title: Pharmacokinetics of YTR830H and piperacillin after intravenous coadministration.
authors.affiliation: Medical Research Division, American Cyanamid Company, Pearl River, NY 10965, USA.
authors.forename: W K
authors.initials: WK
authors.lastname: Cheung
authors.forename: D S
authors.initials: DS
authors.lastname: Greene
authors.forename: O
authors.initials: O
authors.lastname: Kuye
authors.forename: K
authors.initials: K
authors.lastname: Shin
authors.forename: A P
authors.initials: AP
authors.lastname: Tonelli
authors.forename: A
authors.initials: A
authors.lastname: Houston
authors.forename: M
authors.initials: M
authors.lastname: Hibberd
authors.forename: R D
authors.initials: RD
authors.lastname: Faulkner
authors.forename: B M
authors.initials: BM
authors.lastname: Silber
mesh_terms: D000293:Adolescent; D000328:Adult; D019540:Area Under Curve; D004338:Drug Combinations; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics; D006801:Humans; D007262:Infusions, Intravenous; D007700:Kinetics; D008657:Metabolic Clearance Rate; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D010878:Piperacillin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics; D012016:Reference Values; D000078142:Tazobactam
chemical_list: D004338:Drug Combinations; D004791:Enzyme Inhibitors; D010397:Penicillanic Acid; D000078142:Tazobactam; D010878:Piperacillin